SILVER OAK SECURITIES, INCORPORATED
Broker-DealerPosition in NVO — Novo Nordisk A S
CIK 1080576
JACKSON, TN
Position in NVO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$618,953
+$142,085 QoQ
Shares Held
12,911
-0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#647
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SILVER OAK SECURITIES, INCORPORATED holds $18,688,725 across 10 Drug Manufacturers - General names. NVO ranks #5 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
25,544 | $6,427,892 | |
| 2 | LLY |
ELI LILLY & Co
|
4,636 | $5,560,557 | |
| 3 | JNJ |
Johnson & Johnson
|
10,822 | $2,748,463 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,556 | $1,227,946 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
12,911 | $618,953 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
9,134 | $526,301 | |
| 7 | AMGN |
Amgen Inc
|
1,418 | $513,486 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,641 | $460,003 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $618,953 | 12,911 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $476,868 | 12,976 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $552,353 | 10,856 | Shares | Sole | 2026-01-15 | |
| No filing history on record for this holder in this stock. | ||||||